3 completed, 1 recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Integrative Research Laboratories AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy IRL757, Placebo - PARKINSON DISEASE (Disorder), Apathy | Phase 1 / Phase 2 | Recruiting | Integrative Research Laboratories AB | 75 | 2026-02-18 | 2026-09-03 |
| Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers IRL757 - Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects, Apathy | Phase 1 | Completed | Integrative Research Laboratories AB | 12 | 2024-09-23 | 2026-02-05 |
| First-In-Human (FIH) Trial Evaluating the Safety and Tolerability of Single and Multiple Ascending Oral Doses of IRL757 in Healthy Volunteers IRL757, Placebo - Not Determined | Phase 1 | Completed | Integrative Research Laboratories AB | 82 | 2024-05-16 | 2026-05-15 |
| A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia IRL790, Placebo - Parkinson Disease | Phase 1 / Phase 2 | Completed | Integrative Research Laboratories AB | 15 | 2016-11-08 | 2018-05-21 |
Lethargy (2) · Parkinson Disease (2)
mesdopetam (1)
Sweden (2) · Bulgaria (1) · Germany (1) · Poland (1) · Spain (1)